Drug information for CYTADREN

Form	Dosage	Status	Therapeutic Equivalence	Active Ingred	Ref.	Sponsor	Document
TABLET; ORAL	250MG	Discontinued		AMINOGLUTETHIMIDE	Aminoglutethimide	NOVARTIS	18202 2003-05-30 Letter 2003-05-13 Label

Drug Adverse Effects information for CYTADREN

Role code	Indications	Reaction	# Reports
C	HYPERTENSION	ACUTE CORONARY SYNDROME	5
C	HYPERTENSION	ACUTE MYOCARDIAL INFARCTION	5
C	HYPERTENSION	ARTERIOSCLEROSIS CORONARY ARTERY	5
C	HYPERTENSION	CORONARY ARTERY STENOSIS	5
C	HYPERTENSION	MYOCARDIAL ISCHAEMIA	5
C	HYPERTENSION	RESPIRATORY TRACT INFECTION	5
C	HYPERTENSION	TROPONIN INCREASED	5
C	PRODUCT USED FOR UNKNOWN INDICATION	ACUTE CORONARY SYNDROME	8
C	PRODUCT USED FOR UNKNOWN INDICATION	ACUTE MYOCARDIAL INFARCTION	8
C	PRODUCT USED FOR UNKNOWN INDICATION	ARTERIOSCLEROSIS CORONARY ARTERY	8
C	PRODUCT USED FOR UNKNOWN INDICATION	CORONARY ARTERY STENOSIS	8
C	PRODUCT USED FOR UNKNOWN INDICATION	MYOCARDIAL ISCHAEMIA	8
C	PRODUCT USED FOR UNKNOWN INDICATION	RESPIRATORY TRACT INFECTION	8
C	PRODUCT USED FOR UNKNOWN INDICATION	TROPONIN INCREASED	8
C	PROSTATE CANCER	ACUTE CORONARY SYNDROME	2
C	PROSTATE CANCER	ACUTE MYOCARDIAL INFARCTION	2
C	PROSTATE CANCER	ARTERIOSCLEROSIS CORONARY ARTERY	2
C	PROSTATE CANCER	CORONARY ARTERY STENOSIS	2
C	PROSTATE CANCER	MYOCARDIAL ISCHAEMIA	2
C	PROSTATE CANCER	RESPIRATORY TRACT INFECTION	2
C	PROSTATE CANCER	TROPONIN INCREASED	2
C	PROSTATE CANCER METASTATIC	ACUTE CORONARY SYNDROME	1
C	PROSTATE CANCER METASTATIC	ACUTE MYOCARDIAL INFARCTION	1
C	PROSTATE CANCER METASTATIC	ARTERIOSCLEROSIS CORONARY ARTERY	1
C	PROSTATE CANCER METASTATIC	CORONARY ARTERY STENOSIS	1
C	PROSTATE CANCER METASTATIC	MYOCARDIAL ISCHAEMIA	1
C	PROSTATE CANCER METASTATIC	RESPIRATORY TRACT INFECTION	1
C	PROSTATE CANCER METASTATIC	TROPONIN INCREASED	1

Ads by Google